Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
A randomized double-blind placebo controlled trial comparing the effect of a combined
ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block
on procedure related pain with office hysteroscopies.
Age: 18 years - 66+
Gender: Female
Healing Track Clinical Trial
This is a randomized clinical trial to evaluate a digital pain reprocessing therapy (PRT)
intervention for chronic back pain (CBP).
The purpose of this research is to test whether a new digital treatment for chronic pain
works as well as traditional treatments for ...
Age: 21 - 70 years
Gender: All
Vestibular Innovation in Pain
The VIP trial will assess the effectiveness, tolerability, and durability of effect of
vestibulocortical stimulation (VCS) - a safe & cost-effective bedside technique - in
treating pain, fatigue & related symptoms using validated patient-reported outcomes. Data
from ...
Age: 18 - 99 years
Gender: All
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness,
swelling), in the digestive tract, most frequently affecting the bowels. It can cause
many different symptoms including belly pain, diarrhea, tiredness, and weight loss.
Treatmen...
Age: 18 - 75 years
Gender: All
Behavioral Therapy for Crohn's Disease
People living with Crohn's disease (CD) experience psychological and emotional symptoms,
in addition to known chronic and disabling physical symptoms, which prevent them from
living their life to the fullest (flourishing). Depression and anxiety are experienced by
30...
Age: 18 - 65 years
Gender: All
Intrathecal Dexmedetomidine Vs Epinephrine
Several studies have shown that adding dexmedetomidine or epinephrine to single-dose
spinal analgesia preparations improves the length and/or speed of onset of the sensory
block and post-operative pain management without increased negative side effects. To
date, howe...
Age: 18 - 55 years
Gender: Female
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness,
swelling), in the digestive tract, most often affecting the bowels. It can cause many
different symptoms including abdominal pain, diarrhea, tiredness, and weight loss. This
stud...
Age: 2 - 17 years
Gender: All
Erector Spinae Plane Block With Bupivacaine for Medical Thoracoscopy
PlAcebo versus erector spINae pLane block for mEdical ThoracoScopy Study (PAINLESS). This is
a prospective triple-blind, randomized controlled trial that evaluates the efficacy of
erector spinae plane block (ESPB) with Bupivacaine in reducing pain after medical
th...
Age: 18 years - 66+
Gender: All
Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain
Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This ...
Age: 18 years - 66+
Gender: All
Neurocognitive and Genomic Predictors of Persistent Pain and Opioid Misuse After Spine Surgery
Having spine surgery and recovery is a vulnerable period when opioid naive patients may
transition into long-term use of opioids, and when previously opioid tolerant patients
may be at risk to continue towards long-term opioid use and dependence. However, little
is k...
Age: 18 years - 66+
Gender: All
Transcutaneous Electrical Nerve Stimulation (TENS) for IUD Insertion Pain
This study is a double-blind, randomized, placebo-controlled trial to evaluate the use of high frequency TENS for pain control during IUD insertion. Transcutaneous electrical nerve stimulation (TENS) is a relatively low-cost, low-risk, non-pharmacologic intervention for...
Age: 18 years - 66+
Gender: All
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
To investigate the efficacy of MT-7117 on time to onset and severity of first prodromal
symptoms (burning, tingling, itching, or stinging) associated with sunlight exposure in
adults and adolescents with EPP or XLP.
Age: 12 - 75 years
Gender: All
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease (CD) is a gastrointestinal disease that can cause chronic diarrhea with
or without gross bleeding, abdominal pain, weight loss, and fever. This study will assess
the pharmacokinetics, efficacy, and safety of risankizumab in pediatric participants with
...
Age: 2 - 17 years
Gender: All
A Phase 3, SingleArm, OpenLabel Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are 18 to 50 Years of Age and at Risk for Pregnancy
The purpose of this study is to evaluate if relugolix, given with low-dose estradiol (estrogen) and norethindrone acetate (progesterone) (referred to as relugolix combination therapy) is safe and works in the prevention of pregnancy in women with uterine fibroids or end...
Age: 18 - 50 years
Gender: Female
Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain
A randomized, double blind, study of dronabinol as a palliative agent in the treatment of
pain, inflammation, and other complications of sickle cell disease (SCD).
Age: 18 years - 66+
Gender: All
EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA
The purpose of this study is to investigate the safety and efficacy of the current hard
gelatin capsule formulation of NRD135S.E1 80 mg once daily in the treatment of PDPN when
administered for 13 weeks.
Age: 18 years - 66+
Gender: All
EPPIC-Net: Platform Protocol to Assess Treatments for Painful Diabetic Peripheral Neuropathy
This is a Platform Protocol to perform Phase II clinical trials in The Early Phase Pain
Investigation Clinical Network (EPPIC-Net), under The Helping to End Addiction
Long-termSM Initiative, or NIH HEAL InitiativeSM, related to the treatment of Painful
Diabetic Perip...
Age: 18 years - 66+
Gender: All
A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
In this study, researchers will learn more about a study drug called BIIB122 in participants
with early-stage Parkinson's disease (PD). The study will focus on participants with a
specific genetic variant in their LRRK2 gene.
The main question researchers are tr...
Age: 30 - 80 years
Gender: All
The Efficacy of a Subanesthetic Doses of IV Ketamine in the Treatment Drug Resistant Epilepsy
Ketamine is a medication that came into clinical practice in the 1960's. Ketamine is used
as an anesthetic and to provide pain relief. Recently, Ketamine was approved to treat
drug resistant depression using subanesthetic doses. In the hospital setting, intravenous
a...
Age: 18 years - 66+
Gender: All
Chronic Pain Diagnosis and Treatment in Torture Survivors
The goal Aim 1 of this investigation is to characterize the diagnosis of chronic pain in
torture survivors. The investigators hypothesize that using a validated pain screen to
supplement the existing United Nations Istanbul Protocol can improve the ability to
detect ...
Age: 18 years - 66+
Gender: All